Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus retinitis

Medical Microbiology and Immunology

Volumn 202, Issue 1, 2013, Pages 37-47

  Vogel, Jens Uwe ^a,b   Otte, Jürgen ^b   Koch, Frank ^a   Gümbel, Hermann ^c   Doerr, Hans Wilhelm ^a   Cinatl Jr , Jindrich ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Frankfurter Stiftung für Krebskranke Kinder ^*  (Germany)

^c BUNDESWEHRKRANKENHAUS ULM   (Germany)

Author keywords

AIDS; Cytomegalovirus; Retinitis; Viral tropism and virulence

Indexed keywords

ANTIRETROVIRUS AGENT; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADAPTIVE IMMUNITY; ADULT; AIDS PATIENT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS RETINITIS; GENE REPLICATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INNATE IMMUNITY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHYLOGENETIC TREE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; SCHOOL CHILD; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; TROPISM; UL128 GENE; UL130 GENE; UL131A GENE; VIRUS ENTRY; VIRUS GENE; VIRUS GENOME; VIRUS STRAIN; VIRUS VIRULENCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CELL LINE; CHILD; CLUSTER ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS RETINITIS; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; URINE; VIRAL PROTEINS; VITREOUS BODY;

EID: 84873409265     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-012-0244-3     Document Type: Article

References (71)

1. Heinemann MH (1992) Characteristics of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Am J Med 92(2A):12S-16S
2. Coskuncan NM, Jabs DA, Dunn JP, Haller JA, Green WR, Vogelsang GB et al (1994) The eye in bone marrow transplantation. VI. Retinal complications. Arch Ophthalmol 112(3):372-379
3. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5 (1997) Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Am J Ophthalmol 124(2):141-157
4. Allen A, Beeman HW, Christensen L (1957) Cytomegalic inclusion disease. AMA Arch Ophthalmol 57(1):90-99
5. Neuwirth J, Gutman I, Hofeldt AJ, Behrens M, Marquardt MD, Abramovsky-Kaplan I et al (1982) Cytomegalovirus retinitis in a young homosexual male with acquired immunodeficiency. Ophthalmology 89(7):805-808
6. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE (1992) Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis 166(6):1223-1227
7. Collier AC, Meyers JD, Corey L, Murphy VL, Roberts PL, Handsfield HH (1987) Cytomegalovirus infection in homosexual men. Relationship to sexual practices, antibody to human immunodeficiency virus, and cell-mediated immunity. Am J Med 82(3 Spec No):593-601
8. Pillay D, Griffiths PD (1992) Diagnosis of cytomegalovirus infection: a review. Genitourin Med 68(3):183-188
9. Palella FJ, Jr., Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338(13):853-60
10. Holtzer CD, Jacobson MA, Hadley WK, Huang L, Stanley HD, Montanti R et al (1998) Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997. AIDS 12(14):1931-1933
11. Forrest DM, Seminari E, Hogg RS, Yip B, Raboud J, Lawson L et al (1998) The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs. Clin Infect Dis 27(6):1379-1385
12. Holbrook JT, Davis MD, Hubbard LD, Martin BK, Holland GN, Jabs DA et al (2000) Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Studies of ocular complications of AIDS research group. Arch Ophthalmol 118(9):1196-1204
13. Hodge WG, Boivin JF, Shapiro SH, Lalonde RG, Shah KC, Murphy BD et al (2004) Laboratory-based risk factors for cytomegalovirus retinitis. Can J Ophthalmol 39(7):733-745
14. Hodge WG, Boivin JF, Shapiro SH, Lalonde RG, Shah KC, Murphy BD et al (2004) Clinical risk factors for cytomegalovirus retinitis in patients with AIDS. Ophthalmology 111(7):1326-1333
15. Jabs DA, Holbrook JT, Van Natta ML, Clark R, Jacobson MA, Kempen JH et al (2005) Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology 112(5):771-779
16. Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL (2006) Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology 113(8):1432-1440
17. Scholz M, Doerr HW, Cinatl J (2003) Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistence. Trends Microbiol 11(4):171-178
18. Chou SW, Dennison KM (1991) Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 163(6):1229-1234
19. Benedict CA, Butrovich KD, Lurain NS, Corbeil J, Rooney I, Schneider P et al (1999) Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J Immunol 162(12):6967-6970
20. Quinnan GV Jr, Burns WH, Kirmani N, Rook AH, Manischewitz J, Jackson L et al (1984) HLA-restricted cytotoxic T lymphocytes are an early immune response and important defense mechanism in cytomegalovirus infections. Rev Infect Dis 6(2):156-163
21. Brutkiewicz RR, Welsh RM (1995) Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells. J Virol 69(7):3967-3971
22. Lurain NS, Kapell KS, Huang DD, Short JA, Paintsil J, Winkfield E et al (1999) Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates. J Virol 73(12):10040-10050
23. Grundy JE, Lawson KM, MacCormac LP, Fletcher JM, Yong KL (1998) Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration. J Infect Dis 177(6):1465-1474
24. Gerna G, Baldanti F, Revello MG (2004) Pathogenesis of human cytomegalovirus infection and cellular targets. Hum Immunol 65(5):381-386
25. Revello MG, Gerna G (2010) Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications. Rev Med Virol 20(3):136-155
26. Hahn G, Revello MG, Patrone M, Percivalle E, Campanini G, Sarasini A et al (2004) Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol 78(18):10023-10033
27. Wang D, Shenk T (2005) Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc Natl Acad Sci USA 102(50):18153-18158
28. Wang D, Shenk T (2005) Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism. J Virol 79(16):10330-10338
29. Adler B, Scrivano L, Ruzcics Z, Rupp B, Sinzger C, Koszinowski U (2006) Role of human cytomegalovirus UL131A in cell type-specific virus entry and release. J Gen Virol 87(Pt 9):2451-2460
30. Ryckman BJ, Jarvis MA, Drummond DD, Nelson JA, Johnson DC (2006) Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J Virol 80(2):710-722
31. Ryckman BJ, Rainish BL, Chase MC, Borton JA, Nelson JA, Jarvis MA et al (2008) Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J Virol 82(1):60-70
32. Vogel JU, Fleckenstein C, Wagner M, Gümbel HO, Theegarten D, Cinatl J Jr et al (2005) The human eye (retina): a site of persistent HCMV infection? Graefes Arch Clin Exp Ophthalmol 243(7):671-676
33. Hansen SG, Powers CJ, Richards R, Ventura AB, Ford JC, Siess D et al (2010) Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science 328(5974):102-106
34. Rasmussen L (1999) Molecular pathogenesis of human cytomegalovirus infection. Transpl Infect Dis 1(2):127-134
35. Cinatl J, Cinatl J, Weber B, Rabenau H, Gümbel HO, Chenot JF et al (1995) In vitro inhibition of human cytomegalovirus replication in human foreskin fibroblasts and endothelial cells by ascorbic acid 2-phosphate. Antiviral Res 27(4):405-418
36. Cinatl J Jr, Blaheta R, Bittoova M, Scholz M, Margraf S, Vogel JU et al (2000) Decreased neutrophil adhesion to human cytomegalovirus-infected retinal pigment epithelial cells is mediated by virus-induced up-regulation of Fas ligand independent of neutrophil apoptosis. J Immunol 165(8):4405-4413
37. Cinatl J Jr, Margraf S, Vogel JU, Scholz M, Cinatl J, Doerr HW (2001) Human cytomegalovirus circumvents NF-kappa B dependence in retinal pigment epithelial cells. J Immunol 167(4):1900-1908
38. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl Acids Res 22(22):4673-4680
39. Grazia RM, Baldanti F, Percivalle E, Sarasini A, De Giuli L, Genini E et al (2001) In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells. J Gen Virol 82(Pt 6):1429-1438
40. Dargan DJ, Douglas E, Cunningham C, Jamieson F, Stanton RJ, Baluchova K et al (2010) Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture. J Gen Virol 91(Pt 6):1535-1546
41. Bale JF Jr, Petheram SJ, Robertson M, Murph JR, Demmler G (2001) Human cytomegalovirus a sequence and UL144 variability in strains from infected children. J Med Virol 65(1):90-96
42. Akter P, Cunningham C, McSharry BP, Dolan A, Addison C, Dargan DJ et al (2003) Two novel spliced genes in human cytomegalovirus. J Gen Virol 84(Pt 5):1117-1122
43. Bodaghi B, Slobbe-van Drunen ME, Topilko A, Perret E, Vossen RC, Dam-Mieras MC et al (1999) Entry of human cytomegalovirus into retinal pigment epithelial and endothelial cells by endocytosis. Invest Ophthalmol Vis Sci 40(11):2598-2607
44. d'Arminio MA, Mainini F, Testa L, Vago L, Balotta L, Nebuloni M et al (1997) Predictors of cytomegalovirus disease, natural history and autopsy findings in a cohort of patients with AIDS. AIDS 11(4):517-524
45. Hoover DR, Peng Y, Saah A, Semba R, Detels RR, Rinaldo CR Jr et al (1996) Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol 114(7):821-827
46. Saillour F, Bernard N, Dequae-Merchadou L, Marimoutou C, Journot V, Dabis F (1994) Predictive factors of occurrence of cytomegalovirus disease and impact on survival in the Aquitaine Cohort in France, 1985 to 1994. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine. J Acquir Immune Defic Syndr Hum Retrovirol 17(2):171-178
47. Alford CA, Britt WJ (1990) Cytomegalovirus. In: Fields BN, Knipe RM, Chanock MS, Hirsch MS, Melnick JL, Monath TP et al (eds) Fields virology. Raven Press, New York, pp 1981-2010
48. Weber B, Klinghardt U, Lux A, Braun W, Rabenau H, Doerr HW (1993) Detection of neutralizing antibodies against human cytomegalovirus: influence of strain variation. J Med Virol 40(1):28-34
49. Pignatelli S, Dal Monte P, Rossini G, Landini MP (2004) Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev Med Virol 14(6):383-410
50. Shepp DH, Match ME, Ashraf AB, Lipson SM, Millan C, Pergolizzi R (1996) Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J Infect Dis 174(1):184-187
51. Chern KC, Chandler DB, Martin DF, Kuppermann BD, Wolitz RA, Margolis TP (1998) Glycoprotein B subtyping of cytomegalovirus (CMV) in the vitreous of patients with AIDS and CMV retinitis. J Infect Dis 178(4):1149-1153
52. Gilbert C, Handfield J, Toma E, Lalonde R, Bergeron MG, Boivin G (1999) Human cytomegalovirus glycoprotein B genotypes in blood of AIDS patients: lack of association with either the viral DNA load in leukocytes or presence of retinitis. J Med Virol 59(1):98-103
53. Fidouh-Houhou N, Duval X, Bissuel F, Bourbonneux V, Flandre P, Ecobichon JL et al (2001) Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patients. Clin Infect Dis 33(8):1406-1411
54. Drew WL, Chou S, Miner RC, Mohr BA, Busch MP, van der Horst CM et al (2002) Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis. J Infect Dis 186(1):114-117
55. Zipeto D, Hong C, Gerna G, Zavattoni M, Katzenstein D, Merigan TC et al (1998) Geographic and demographic differences in the frequency of human cytomegalovirus gB genotypes 1-4 in immunocompromised patients. AIDS Res Hum Retroviruses 14(6):533-536
56. Lewallen S, Courtright P (1997) HIV and AIDS and the eye in developing countries: a review. Arch Ophthalmol 115(10):1291-1295
57. Shepp DH, Match ME, Lipson SM, Pergolizzi RG (1998) A fifth human cytomegalovirus glycoprotein B genotype. Res Virol 149(2):109-114
58. Trincado DE, Scott GM, White PA, Hunt C, Rasmussen L, Rawlinson WD (2000) Human cytomegalovirus strains associated with congenital and perinatal infections. J Med Virol 61(4):481-487
59. Cha TA, Tom E, Kemble GW, Duke GM, Mocarski ES, Spaete RR (1996) Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 70(1):78-83
60. Revello MG, Campanini G, Piralla A, Furione M, Percivalle E, Zavattoni M et al (2008) Molecular epidemiology of primary human cytomegalovirus infection in pregnant women and their families. J Med Virol 80(8):1415-1425
61. Arav-Boger R, Willoughby RE, Pass RF, Zong JC, Jang WJ, Alcendor D et al (2002) Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-alpha and beta-chemokine receptors in congenital CMV disease. J Infect Dis 186(8):1057-1064
62. Arav-Boger R, Battaglia CA, Lazzarotto T, Gabrielli L, Zong JC, Hayward GS et al (2006) Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection. J Infect Dis 194(4):464-473
63. Picone O, Costa JM, Chaix ML, Ville Y, Rouzioux C, Leruez-Ville M (2005) Human cytomegalovirus UL144 gene polymorphisms in congenital infections. J Clin Microbiol 43(1):25-29
64. Prichard MN, Penfold ME, Duke GM, Spaete RR, Kemble GW (2001) A review of genetic differences between limited and extensively passaged human cytomegalovirus strains. Rev Med Virol 11(3):191-200
65. Poole E, King CA, Sinclair JH, Alcami A (2006) The UL144 gene product of human cytomegalovirus activates NFkappaB via a TRAF6-dependent mechanism. EMBO J 25(18):4390-4399
66. Poole E, Groves I, MacDonald A, Pang Y, Alcami A, Sinclair J (2009) Identification of TRIM23 as a cofactor involved in the regulation of NF-kappaB by human cytomegalovirus. J Virol 83(8):3581-3590
67. Adler B, Sinzger C (2009) Endothelial cells in human cytomegalovirus infection: one host cell out of many or a crucial target for virus spread? Thromb Haemost 102(6):1057-1063
68. Compton T, Nepomuceno RR, Nowlin DM (1992) Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface. Virology 191(1):387-395
69. Vanarsdall AL, Chase MC, Johnson DC (2011) Human cytomegalovirus glycoprotein gO complexes with gH/gL, promoting interference with viral entry into human fibroblasts but not entry into epithelial cells. J Virol 85(22):11638-11645
70. Baldanti F, Paolucci S, Campanini G, Sarasini A, Percivalle E, Revello MG et al (2006) Human cytomegalovirus UL131A, UL130 and UL128 genes are highly conserved among field isolates. Arch Virol 151(6):1225-1233
71. Detrick B, Rhame J, Wang Y, Nagineni CN, Hooks JJ (1996) Cytomegalovirus replication in human retinal pigment epithelial cells. Altered expression of viral early proteins. Invest Ophthalmol Vis Sci 37(5):814-825